Just a moment, the page is loading...

*EISAI-E2007-G000-304




A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
perampanel
E2007-G000-304
NCT00699972
EU CTR 2007-006191-11
Refractory Partial Seizures
Phase 3
 
No restrictions.
November 2018